Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Return on Equity: 2022-2025

Historic Return on Equity for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Sep 2025 value amounting to -0.75%.

  • Centessa Pharmaceuticals' Return on Equity fell 34.00% to -0.75% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.75%, marking a year-over-year decrease of 34.00%. This contributed to the annual value of -0.74% for FY2024, which is 21.00% down from last year.
  • According to the latest figures from Q3 2025, Centessa Pharmaceuticals' Return on Equity is -0.75%, which was down 19.15% from -0.63% recorded in Q2 2025.
  • Centessa Pharmaceuticals' 5-year Return on Equity high stood at -0.41% for Q3 2024, and its period low was -0.75% during Q3 2025.
  • For the 3-year period, Centessa Pharmaceuticals' Return on Equity averaged around -0.60%, with its median value being -0.61% (2023).
  • Per our database at Business Quant, Centessa Pharmaceuticals' Return on Equity climbed by 18bps in 2024 and then crashed by 34bps in 2025.
  • Over the past 4 years, Centessa Pharmaceuticals' Return on Equity (Quarterly) stood at -0.61% in 2022, then remained steady at -0.61% in 2023, then rose by 9bps to -0.52% in 2024, then slumped by 34bps to -0.75% in 2025.
  • Its Return on Equity was -0.75% in Q3 2025, compared to -0.63% in Q2 2025 and -0.57% in Q1 2025.